4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001415889-25-000601
Options or other derivatives
- Chief Financial Officer acquired 236,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Piscitelli Dominic Chief Financial Officer | 2025-01-02 | Grant or award · Stock Option (right to buy) | +202,500 | 202,500 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2025-01-02 | Grant or award · Restricted Stock Unit | +34,000 | 34,000 | D | ||
Loading xslF345X05/form4-01032025_100150.xml…